title: Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats.
authors.forename: Sayaka
authors.initials: S
authors.lastname: Maeda
authors.forename: Takanori
authors.initials: T
authors.lastname: Matsui
authors.forename: Sho-Ichi
authors.initials: S
authors.lastname: Yamagishi
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D003921:Diabetes Mellitus, Experimental; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D008297:Male; D009570:Nitriles / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects*; D011759:Pyrrolidines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077597:Vildagliptin
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D009570:Nitriles; D011759:Pyrrolidines; D000077597:Vildagliptin; D000218:Adamantane